These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38133068)

  • 1. Correction: Santonocito et al. Astaxanthin-Loaded Stealth Lipid Nanoparticles (AST-SSLN) as Potential Carriers for the Treatment of Alzheimer's Disease: Formulation Development and Optimization.
    Santonocito D; Raciti G; Campisi A; Sposito G; Panico A; Siciliano EA; Sarpietro MG; Damiani E; Puglia C
    Nanomaterials (Basel); 2023 Dec; 13(24):. PubMed ID: 38133068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astaxanthin-Loaded Stealth Lipid Nanoparticles (AST-SSLN) as Potential Carriers for the Treatment of Alzheimer's Disease: Formulation Development and Optimization.
    Santonocito D; Raciti G; Campisi A; Sposito G; Panico A; Siciliano EA; Sarpietro MG; Damiani E; Puglia C
    Nanomaterials (Basel); 2021 Feb; 11(2):. PubMed ID: 33546352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and evaluation of stealth Tashinone IIA-loaded solid lipid nanoparticles: Influence of Poloxamer 188 coating on phagocytic uptake.
    Zhang W; Liu J; Li S; Chen M; Liu H
    J Microencapsul; 2008 May; 25(3):203-9. PubMed ID: 18382927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Donepezil with Astaxanthin via Nanostructured Lipid Carriers Effective Delivery to Brain for Alzheimer's Disease in Rat Model.
    Shehata MK; Ismail AA; Kamel MA
    Int J Nanomedicine; 2023; 18():4193-4227. PubMed ID: 37534058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nose to Brain Delivery of Astaxanthin-Loaded Nanostructured Lipid Carriers in Rat Model of Alzheimer's Disease: Preparation, in vitro and in vivo Evaluation.
    Shehata MK; Ismail AA; Kamel MA
    Int J Nanomedicine; 2023; 18():1631-1658. PubMed ID: 37020692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues.
    Zara GP; Cavalli R; Bargoni A; Fundarò A; Vighetto D; Gasco MR
    J Drug Target; 2002 Jun; 10(4):327-35. PubMed ID: 12164381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of paclitaxel delivery system based on semi-solid lipid nanoparticles coated with poly (ethylene glycol).
    Wu L; Tang C; Yin C
    Pharmazie; 2010 Jul; 65(7):493-9. PubMed ID: 20662317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-Mediated Targeting in Breast Cancer through Solid Lipid Nanoparticles and Its Mechanism.
    Malik Z; Parveen R; Abass S; Irfan Dar M; Husain SA; Ahmad S
    Curr Drug Metab; 2022; 23(10):800-817. PubMed ID: 35430962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Berberine loaded nanostructured lipid carrier for Alzheimer's disease: Design, statistical optimization and enhanced in vivo performance.
    Raju M; Kunde SS; Auti ST; Kulkarni YA; Wairkar S
    Life Sci; 2021 Nov; 285():119990. PubMed ID: 34592234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astaxanthin-Loaded Nanostructured Lipid Carriers for Preservation of Antioxidant Activity.
    Rodriguez-Ruiz V; Salatti-Dorado JÁ; Barzegari A; Nicolas-Boluda A; Houaoui A; Caballo C; Caballero-Casero N; Sicilia D; Bastias Venegas J; Pauthe E; Omidi Y; Letourneur D; Rubio S; Gueguen V; Pavon-Djavid G
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30314284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation of 10-hydroxycamptothecin semisolid lipid nanoparticles and investigation of its stability].
    Xi N; Hou LB; Yan XQ; Jiang QF; Wang CX
    Zhong Yao Cai; 2006 Jan; 29(1):63-6. PubMed ID: 16722323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Astaxanthin and Docosahexaenoic-Acid-Acylated Astaxanthin on Alzheimer's Disease in APP/PS1 Double-Transgenic Mice.
    Che H; Li Q; Zhang T; Wang D; Yang L; Xu J; Yanagita T; Xue C; Chang Y; Wang Y
    J Agric Food Chem; 2018 May; 66(19):4948-4957. PubMed ID: 29695154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double Optimization of Rivastigmine-Loaded Nanostructured Lipid Carriers (NLC) for Nose-to-Brain Delivery Using the Quality by Design (QbD) Approach: Formulation Variables and Instrumental Parameters.
    Cunha S; Costa CP; Loureiro JA; Alves J; Peixoto AF; Forbes B; Sousa Lobo JM; Silva AC
    Pharmaceutics; 2020 Jun; 12(7):. PubMed ID: 32605177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, Characterization, and In Vitro Anticancer Activity Evaluation of Broccoli-Derived Extracellular Vesicle-Coated Astaxanthin Nanoparticles.
    Li C; Song Q; Yin X; Song R; Chen G
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35745077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An In Vitro Evaluation of the Potential Neuroprotective Effects of Intranasal Lipid Nanoparticles Containing Astaxanthin Obtained from Different Sources: Comparative Studies.
    Torres J; Pereira JM; Marques-Oliveira R; Costa I; Gil-Martins E; Silva R; Remião F; Peixoto AF; Sousa Lobo JM; Silva AC
    Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theranostic Applications of Nanomaterials in Alzheimer's Disease: A Multifunctional Approach.
    Tripathi P; Shukla P; Bieberich E
    Curr Pharm Des; 2022; 28(2):116-132. PubMed ID: 34809540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of carrier-free astaxanthin nanoparticles with improved antioxidant capacity.
    Yu F; Chen J; Wei Z; Zhu P; Qing Q; Li B; Chen H; Lin W; Yang H; Qi Z; Hong X; Chen XD
    Front Nutr; 2022; 9():1022323. PubMed ID: 36245512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of Astaxanthin microencapsulation in hydrophilic carriers using response surface methodology.
    Nalawade P; Gajjar A
    Arch Pharm Res; 2015 Dec; ():. PubMed ID: 26670178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanocarrier System: State-of-the-Art in Oral Delivery of Astaxanthin.
    Abdol Wahab NR; Meor Mohd Affandi MMR; Fakurazi S; Alias E; Hassan H
    Antioxidants (Basel); 2022 Aug; 11(9):. PubMed ID: 36139750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of astaxanthin-loaded composite micelles with coaxial electrospray technology for enhanced oral bioavailability and improved antioxidation capability.
    Liao Y; Wang H; Li S; Xue Y; Chen Y; Adu-Frimpong M; Xu Y; Yu J; Xu X; Smyth HDC; Zhu Y
    J Sci Food Agric; 2024 Feb; 104(3):1408-1419. PubMed ID: 37782057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.